| Ribosome |
2.05 |
5.93e-3 |
113/158 (71.52%) |
MRPL15;MRPL23;RPL10;...
|
| DNA replication |
2.01 |
5.93e-3 |
34/36 (94.44%) |
POLE2;MCM6;SSBP1;...
|
| Homologous recombination |
1.89 |
1.19e-2 |
35/41 (85.37%) |
SSBP1;RAD51C;MRE11;...
|
| RNA polymerase |
1.84 |
1.48e-2 |
23/31 (74.19%) |
POLR2I;POLR2F;POLR2E;...
|
| Fanconi anemia pathway |
1.79 |
2.14e-2 |
36/54 (66.67%) |
FANCL;CENPX;RAD51C;...
|
| Ribosome biogenesis in eukaryotes |
1.79 |
1.78e-2 |
52/108 (48.15%) |
IMP4;GNL3;IMP3;...
|
| Aminoacyl-tRNA biosynthesis |
1.70 |
3.98e-2 |
15/66 (22.73%) |
IARS2;GATC;NARS2;...
|
| Base excision repair |
1.69 |
3.71e-2 |
29/33 (87.88%) |
POLE2;APEX1;MPG;...
|
| T cell receptor signaling pathway |
-1.64 |
4.46e-2 |
93/104 (89.42%) |
PAK5;PAK6;BCL10;...
|
| Longevity regulating pathway |
-1.64 |
4.57e-2 |
90/151 (59.6%) |
PRKAB1;PIK3CA;PRKACB;...
|
| Retinol metabolism |
-1.64 |
4.64e-2 |
41/68 (60.29%) |
RDH16;ADH7;CYP26B1;...
|
| Lipid and atherosclerosis |
-1.67 |
3.79e-2 |
190/215 (88.37%) |
RXRB;TRAF6;TLR2;...
|
| NF-kappa B signaling pathway |
-1.67 |
3.74e-2 |
90/104 (86.54%) |
TRAF6;NFKBIA;TRAF3;...
|
| Platelet activation |
-1.68 |
3.43e-2 |
106/124 (85.48%) |
TBXA2R;BTK;GNAI1;...
|
| Glycine, serine and threonine metabolism |
-1.70 |
3.21e-2 |
31/40 (77.5%) |
GATM;PSAT1;PHGDH;...
|
| Bacterial invasion of epithelial cells |
-1.70 |
3.29e-2 |
59/77 (76.62%) |
ARPC5L;PIK3CA;CDH1;...
|
| Natural killer cell mediated cytotoxicity |
-1.70 |
3.39e-2 |
99/131 (75.57%) |
CD247;TNFSF10;BRAF;...
|
| mRNA surveillance pathway |
-1.70 |
3.43e-2 |
71/98 (72.45%) |
PABPC3;SRRM1;TARDBP;...
|
| Protein processing in endoplasmic reticulum |
-1.71 |
3.03e-2 |
127/171 (74.27%) |
ERP29;PPP1R15A;HSPA8;...
|
| Inositol phosphate metabolism |
-1.72 |
3.06e-2 |
66/73 (90.41%) |
MTMR3;PLCH1;MTMR1;...
|
| Arginine biosynthesis |
-1.73 |
2.74e-2 |
17/22 (77.27%) |
CPS1;GLUL;ASL;...
|
| Rheumatoid arthritis |
-1.74 |
2.75e-2 |
78/93 (83.87%) |
JUN;CSF2;ATP6V0B;...
|
| Coronavirus disease |
-1.74 |
2.84e-2 |
215/232 (92.67%) |
MAP3K7;MAPK9;RPL28;...
|
| Cholesterol metabolism |
-1.74 |
3.03e-2 |
44/50 (88%) |
LDLRAP1;MYLIP;CETP;...
|
| Lysosome |
-1.79 |
1.80e-2 |
115/128 (89.84%) |
MAN2B1;PPT2;LIPA;...
|
| Chemokine signaling pathway |
-1.82 |
1.26e-2 |
163/192 (84.9%) |
IKBKB;ARRB2;CRK;...
|
| PPAR signaling pathway |
-1.84 |
1.16e-2 |
66/74 (89.19%) |
CPT1A;CPT2;EHHADH;...
|
| Legionellosis |
-1.86 |
5.74e-3 |
51/57 (89.47%) |
CASP9;CR1;SAR1A;...
|
| Pertussis |
-1.87 |
6.31e-3 |
64/76 (84.21%) |
JUN;IRF8;FOS;...
|
| Ferroptosis |
-1.87 |
7.01e-3 |
36/41 (87.8%) |
SAT1;SLC3A2;ACSL4;...
|
| TNF signaling pathway |
-1.87 |
7.89e-3 |
103/112 (91.96%) |
NFKBIA;TRAF3;RIPK1;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.88 |
9.02e-3 |
62/70 (88.57%) |
ATP6V1H;NFKBIA;GIT1;...
|
| Antigen processing and presentation |
-1.92 |
1.05e-2 |
60/78 (76.92%) |
HSPA4;CALR;TAP2;...
|
| Neutrophil extracellular trap formation |
-1.95 |
1.01e-2 |
101/189 (53.44%) |
SLC25A4;CYBB;AZU1;...
|
| Staphylococcus aureus infection |
-2.01 |
3.16e-3 |
72/95 (75.79%) |
PLG;DEFB4A;ITGAM;...
|
| Viral protein interaction with cytokine and cytokine re... |
-2.05 |
4.21e-3 |
84/100 (84%) |
CCL2;CCL21;LTA;...
|
| IL-17 signaling pathway |
-2.10 |
0.00e+0 |
84/94 (89.36%) |
IFNG;MAPK6;TRAF6;...
|
| Complement and coagulation cascades |
-2.60 |
0.00e+0 |
76/85 (89.41%) |
ITGAM;C1QA;SERPINA1;...
|
